4//SEC Filing
Monson Jonathan 4
Accession 0001225208-24-002578
CIK 0000885725other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:04 PM ET
Size
18.4 KB
Accession
0001225208-24-002578
Insider Transaction Report
Form 4
Monson Jonathan
EVP and CFO
Transactions
- Exercise/Conversion
Common Stock
2024-02-16+990→ 37,433 total - Tax Payment
Common Stock
2024-02-16$65.82/sh−427$28,105→ 37,006 total - Exercise/Conversion
Common Stock
2024-02-17+1,000→ 38,006 total - Tax Payment
Common Stock
2024-02-17$65.82/sh−404$26,591→ 37,602 total - Exercise/Conversion
Common Stock
2024-02-18+638→ 38,240 total - Tax Payment
Common Stock
2024-02-18$65.82/sh−258$16,982→ 37,982 total - Exercise/Conversion
Restricted Stock Units
2024-02-16−990→ 1,980 totalExp: 2026-02-16→ Common Stock (990 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-17−1,000→ 1,000 totalExp: 2025-02-17→ Common Stock (1,000 underlying) - Exercise/Conversion
Deferred Stock Units
2024-02-18−638→ 0 totalExp: 2024-02-18→ Common Stock (638 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
- [F3]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
- [F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
- [F5]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001779170
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 9:04 PM ET
- Size
- 18.4 KB